Article Versions Notes

Soudi A, Bender O, Celik I, El-Hafeez AAA, Dogan R, Atalay A, Elkaeed EB, Alsfouk AA, Abdelhafez EMN, Aly OM, et al. Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor. Pharmaceuticals. 2024; 17(5):659. https://doi.org/10.3390/ph17050659

Soudi, Aya, Onur Bender, Ismail Celik, Amer Ali Abd El-Hafeez, Rumeysa Dogan, Arzu Atalay, Eslam B. Elkaeed, Aisha A. Alsfouk, Elshimaa M. N. Abdelhafez, Omar M. Aly, and et al. 2024. "Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor" Pharmaceuticals 17, no. 5: 659. https://doi.org/10.3390/ph17050659

Soudi, A., Bender, O., Celik, I., El-Hafeez, A. A. A., Dogan, R., Atalay, A., Elkaeed, E. B., Alsfouk, A. A., Abdelhafez, E. M. N., Aly, O. M., Sippl, W., & Ali, T. F. S. (2024). Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor. Pharmaceuticals, 17(5), 659. https://doi.org/10.3390/ph17050659